A detailed history of Kelly Financial Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kelly Financial Group LLC holds 18,467 shares of PFE stock, worth $463,152. This represents 0.12% of its overall portfolio holdings.

Number of Shares
18,467
Previous 18,398 0.38%
Holding current value
$463,152
Previous $446 Million 5.51%
% of portfolio
0.12%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$23.29 - $25.88 $1,607 - $1,785
69 Added 0.38%
18,467 $471 Million
Q2 2025

Jul 15, 2025

BUY
$21.59 - $24.84 $21,849 - $25,138
1,012 Added 5.82%
18,398 $446 Million
Q1 2025

Apr 16, 2025

BUY
$25.01 - $27.13 $434,823 - $471,682
17,386 New
17,386 $441 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kelly Financial Group LLC Portfolio

Follow Kelly Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Group LLC with notifications on news.